Home » Topics » Regulatory

Regulatory
RSS

Daiichi Sankyo announces Japanese approvals for supplementary indications

Aug. 25, 2015

FDA approves first treatment for hypoactive sexual desire disorder in women

Aug. 19, 2015

FDA approves Keveyis for primary hyperkalemic and hypokalemic periodic paralysis

Aug. 11, 2015

FDA approves Praluent to treat high LDL cholesterol

July 27, 2015

FDA approves Odomzo for locally advanced BCC

July 27, 2015

Evolocumab becomes first PCSK9 inhibitor approved in the world

July 22, 2015

FDA approves Rexulti for schizophrenia and major depressive disorder

July 13, 2015

FDA approves Entresto to reduce risk of cardiovascular death and heart failure hospitalization

July 8, 2015

Olanedine antiseptic approved in Japan

July 7, 2015

Strensiq receives first approval in Japan for hypophosphatasia

July 7, 2015